lncRNA RP11‑531A24.3 inhibits the migration and proliferation of vascular smooth muscle cells by downregulating ANXA2 expression

Wu,Yilin; Cai,Fen; Lu,Yuanbin; Hu,Yanwei; Wang,Qian

doi:10.3892/etm.2021.10874

lncRNA RP11‑531A24.3 inhibits the migration and proliferation of vascular smooth muscle cells by downregulating ANXA2 expression

Authors:
- Yilin Wu
- Fen Cai
- Yuanbin Lu
- Yanwei Hu
- Qian Wang
View Affiliations

Affiliations: Department of Laboratory Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China
Published online on: October 12, 2021 https://doi.org/10.3892/etm.2021.10874
Article Number: 1439

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A complete understanding of the behavioral influence and phenotypic transition of vascular smooth muscle cells, as well as the effects of the characteristics of these cells on the physiological and pathological processes of atherosclerosis, is crucial if new therapeutic targets for atherosclerosis are to be identified. In the present study, the long non‑coding RNA RP11‑531A24.3 was identified to be expressed at low levels in plaque tissues through screening a microarray for differentially expressed genes. The functional experimental results suggested that RP11‑531A24.3 reduced the viability and inhibited the migration of human aortic vascular smooth muscle cells (HA‑VSMCs). RNA antisense purification‑mass spectrometry was used to identify the RNA‑binding proteins (RBPs) for RP11‑531A24.3. Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis indicated that the pathway with the highest degree of association with RP11‑531A24.3 RBPs was related to cell migration. The reduced migration and viability mediated by RP11‑531A24.3 overexpression was more significantly suppressed after annexin 2 (ANXA2) depletion in RP11‑531A24.3‑overexpressing HA‑VSMCs. Culture of HA‑VSMCs under hypoxic conditions (1% O2) reduced the expression of RP11‑531A24.3, and enhanced the protein expression of ANXA2 and HIF‑1α, while knockdown of ANXA2 downregulated the protein expression of HIF‑1α. These results suggested that RP11‑531A24.3 regulated the proliferation and migration of HA‑VSMCs through ANXA2 expression, and hypoxia may be an external factor in the regulation of RP11‑531A24.3 and its downstream targets.

View Figures

View References

1	Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, et al: Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 70:1–25. 2017.PubMed/NCBI View Article : Google Scholar
2	Song P, Zha M, Yang X, Xu Y, Wang H, Fang Z, Yang X, Xia W and Zeng C: Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese. Atherosclerosis. 282:57–66. 2019.PubMed/NCBI View Article : Google Scholar
3	Lusis AJ: Atherosclerosis. Nature. 407:233–241. 2000.PubMed/NCBI View Article : Google Scholar
4	Bennett MR, Sinha S and Owens GK: Vascular Smooth Muscle Cells in Atherosclerosis. Circ Res. 118:692–702. 2016.PubMed/NCBI View Article : Google Scholar
5	Basatemur GL, Jørgensen HF, Clarke MCH, Bennett MR and Mallat Z: Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol. 16:727–744. 2019.PubMed/NCBI View Article : Google Scholar
6	Williams KJ and Tabas I: The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 15:551–561. 1995.PubMed/NCBI View Article : Google Scholar
7	Tabas I, Williams KJ and Borén J: Subendothelial lipoprotein retention as the initiating process in atherosclerosis: Update and therapeutic implications. Circulation. 116:1832–1844. 2007.PubMed/NCBI View Article : Google Scholar
8	Owens GK, Kumar MS and Wamhoff BR: Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 84:767–801. 2004.PubMed/NCBI View Article : Google Scholar
9	Ferns GAA and Heikal L: Hypoxia in Atherogenesis. Angiology. 68:472–493. 2017.PubMed/NCBI View Article : Google Scholar
10	Jain T, Nikolopoulou EA, Xu Q and Qu A: Hypoxia inducible factor as a therapeutic target for atherosclerosis. Pharmacol Ther. 183:22–33. 2018.PubMed/NCBI View Article : Google Scholar
11	Luque A, Turu M, Juan-Babot O, Cardona P, Font A, Carvajal A, Slevin M, Iborra E, Rubio F, Badimon L, et al: Overexpression of hypoxia/inflammatory markers in atherosclerotic carotid plaques. Front Biosci. 13:6483–6490. 2008.PubMed/NCBI View Article : Google Scholar
12	Consortium EP: ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature. 489:57–74. 2012.PubMed/NCBI View Article : Google Scholar
13	Mishra K and Kanduri C: Understanding Long Noncoding RNA and Chromatin Interactions: What We Know So Far. Noncoding RNA. 5(5)2019.PubMed/NCBI View Article : Google Scholar
14	McDonel P and Guttman M: Approaches for Understanding the Mechanisms of Long Noncoding RNA Regulation of Gene Expression. Cold Spring Harb Perspect Biol. 11(11)2019.PubMed/NCBI View Article : Google Scholar
15	Sauvageau M: Diverging RNPs: Toward Understanding lncRNA-Protein Interactions and Functions. Adv Exp Med Biol. 1203:285–312. 2019.PubMed/NCBI View Article : Google Scholar
16	Leeper NJ and Maegdefessel L: Non-coding RNAs: Key regulators of smooth muscle cell fate in vascular disease. Cardiovasc Res. 114:611–621. 2018.PubMed/NCBI View Article : Google Scholar
17	Kumar S, Williams D, Sur S, Wang JY and Jo H: Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis. Vascul Pharmacol. 114:76–92. 2019.PubMed/NCBI View Article : Google Scholar
18	Holdt LM, Kohlmaier A and Teupser D: Long Noncoding RNAs of the Arterial Wall as Therapeutic Agents and Targets in Atherosclerosis. Thromb Haemost. 119:1222–1236. 2019.PubMed/NCBI View Article : Google Scholar
19	Xu S, Kamato D, Little PJ, Nakagawa S, Pelisek J and Jin ZG: Targeting epigenetics and non-coding RNAs in atherosclerosis: From mechanisms to therapeutics. Pharmacol Ther. 196:15–43. 2019.PubMed/NCBI View Article : Google Scholar
20	Hu YW, Guo FX, Xu YJ, Li P, Lu ZF, McVey DG, Zheng L, Wang Q, Ye JH, Kang CM, et al: Long noncoding RNA NEXN-AS1 mitigates atherosclerosis by regulating the actin-binding protein NEXN. J Clin Invest. 129:1115–1128. 2019.PubMed/NCBI View Article : Google Scholar
21	Bai HL, Lu ZF, Zhao JJ, Ma X, Li XH, Xu H, Wu SG, Kang CM, Lu JB, Xu YJ, et al: Microarray profiling analysis and validation of novel long noncoding RNAs and mRNAs as potential biomarkers and their functions in atherosclerosis. Physiol Genomics. 51:644–656. 2019.PubMed/NCBI View Article : Google Scholar
22	Kanehisa M, Furumichi M, Sato Y, Ishiguro-Watanabe M and Tanabe M: KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res. 49D:D545–D551. 2021.PubMed/NCBI View Article : Google Scholar
23	Gene Ontology C: Gene Ontology Consortium. The Gene Ontology resource: Enriching a GOld mine. Nucleic Acids Res. 49D:D325–D334. 2021.PubMed/NCBI View Article : Google Scholar
24	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
25	Nan A, Chen L, Zhang N, Liu Z, Yang T, Wang Z, Yang C and Jiang Y: A novel regulatory network among lncRpa, circRar1, miR-671 and apoptotic genes promotes lead-induced neuronal cell apoptosis. Arch Toxicol. 91:1671–1684. 2017.PubMed/NCBI View Article : Google Scholar
26	Fukata Y, Amano M and Kaibuchi K: Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci. 22:32–39. 2001.PubMed/NCBI View Article : Google Scholar
27	Webb RC: Smooth muscle contraction and relaxation. Adv Physiol Educ. 27:201–206. 2003.PubMed/NCBI View Article : Google Scholar
28	Lokman NA, Ween MP, Oehler MK and Ricciardelli C: The role of annexin A2 in tumorigenesis and cancer progression. Cancer Microenviron. 4:199–208. 2011.PubMed/NCBI View Article : Google Scholar
29	Mayer G, Poirier S and Seidah NG: Annexin A2 is a C-terminal PCSK9-binding protein that regulates endogenous low density lipoprotein receptor levels. J Biol Chem. 283:31791–31801. 2008.PubMed/NCBI View Article : Google Scholar
30	Ma S, Lu CC, Yang LY, Wang JJ, Wang BS, Cai HQ, Hao JJ, Xu X, Cai Y, Zhang Y, et al: ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis. J Exp Clin Cancer Res. 37(183)2018.PubMed/NCBI View Article : Google Scholar
31	Hussain S, Saxena S, Shrivastava S, Mohanty AK, Kumar S, Singh RJ, Kumar A, Wani SA, Gandham RK, Kumar N, et al: Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis. PLoS One. 13(e0208656)2018.PubMed/NCBI View Article : Google Scholar
32	Tang Y, He Y, Zhang P, Wang J, Fan C, Yang L, Xiong F, Zhang S, Gong Z, Nie S, et al: lncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis. Mol Cancer. 17(77)2018.PubMed/NCBI View Article : Google Scholar
33	Saiki Y and Horii A: Multiple functions of S100A10, an important cancer promoter. Pathol Int. 69:629–636. 2019.PubMed/NCBI View Article : Google Scholar
34	Wang Z, Wei Q, Han L, Cao K, Lan T, Xu Z, Wang Y, Gao Y, Xue J, Shan F, et al: Tenascin-c renders a proangiogenic phenotype in macrophage via annexin II. J Cell Mol Med. 22:429–438. 2018.PubMed/NCBI View Article : Google Scholar
35	Ding P, Ding Y, Tian Y and Lei X: Circular RNA circ_0010283 regulates the viability and migration of oxidized low density lipoprotein induced vascular smooth muscle cells via an miR 370 3p/HMGB1 axis in atherosclerosis. Int J Mol Med. 46:1399–1408. 2020.PubMed/NCBI View Article : Google Scholar
36	Yan Z, Wang H, Liang J, Li Y and Li X: MicroRNA-503-5p improves carotid artery stenosis by inhibiting the proliferation of vascular smooth muscle cells. Exp Ther Med. 20(85)2020.PubMed/NCBI View Article : Google Scholar
37	Deryugina EI and Quigley JP: Cell surface remodeling by plasmin: A new function for an old enzyme. J Biomed Biotechnol. 2012(564259)2012.PubMed/NCBI View Article : Google Scholar
38	Li L, Li X, The E, Wang LJ, Yuan TY, Wang SY, Feng J, Wang J, Liu Y, Wu YH, et al: Low expression of lncRNA-GAS5 is implicated in human primary varicose great saphenous veins. PLoS One. 10(e0120550)2015.PubMed/NCBI View Article : Google Scholar
39	Zhu B, Gong Y, Yan G, Wang D, Qiao Y, Wang Q, Liu B, Hou J, Li R and Tang C: Down-regulation of lncRNA MEG3 promotes hypoxia-induced human pulmonary artery smooth muscle cell proliferation and migration via repressing PTEN by sponging miR-21. Biochem Biophys Res Commun. 495:2125–2132. 2018.PubMed/NCBI View Article : Google Scholar